Researchers compared the safety and efficacy of two direct oral anticoagulants (DOACs), apixaban and rivaroxaban, ... In a study in the European Stroke Journal, researchers compared once-daily direct oral anticoagulant (DOAC) use, ... According to a study, published in Age and Ageing, the association between direct oral anticoagulant (DOAC) use and ... Researchers performed a meta-analysis to assess the safety and efficacy of direct oral anticoagulants (DOAC) for ... In the pilot study, ORIGAMI, researchers investigated whether direct oral anticoagulants (DOACs) could be safely used to ... According to a study published in Cardiovascular Intervention and Therapeutics, the safety and efficacy profiles of left ... The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the U.S. Food and Drug ... Diabetes mellitus (DM) is a common comorbidity in patients with atrial fibrillation (AF) and is associated with an ... In patients with a first unprovoked venous thromboembolism (VTE), the long-term risks and consequences of ... The third most common factor associated with cardiovascular death is venous thromboembolism (VTE), including deep vein ... Lower Blood Pressure at Hospital Admission Increases the Risk of Heart Failure Death
... A new study found that under-dosing of direct oral anticoagulants (DOACs) in patients with extreme obesity and atrial ... A new study shows that hospitalized patients with SARS-CoV-2 (COVID-19) are more likely to have venous thromboembolism ... In assessing hemorrhage risk factors for venous thromboembolism (VTE) patients taking direct oral anticoagulants ... A Scandinavian study suggested that the use of direct oral anticoagulants in patients with venous thromboembolism (VTE) ... According to data presented at the 2020 American Society of Hematology Annual Meeting & Exposition, the use of ... A recent study in the Journal of the American Heart Association suggests that direct oral anticoagulants and ... A study published in Experimental and Therapeutic Medicine showed direct anti-inflammatory potential of direct oral ... Patients with chronic kidney disease (CKD) and non-valvular atrial fibrillation (NVAF) were more likely to use vitamin K ... Direct oral anticoagulants (DOACs) showed promise as alternatives to low molecular weight heparin (LMWH) or vitamin K ...